Guomu C. Liu
Xinjiang Street 125
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023.
Journal: Frontiers in endocrinology
Published: May 18, 2026
T cell-mediated immune responses in xenotransplantation: mechanisms and therapeutic strategies.
Journal: Frontiers in immunology
Published: December 15, 2025
Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data
Journal: Zhonghua fu chan ke za zhi
Published: April 21, 2024
Heterogeneity and plasticity of tissue-resident memory T cells in skin diseases and homeostasis: a review.
Journal: Frontiers in immunology
Published: January 29, 2024
Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice.
Journal: International immunopharmacology
Published: April 10, 2023
MF59 Promoted the Combination of CpG ODN1826 and MUC1-MBP Vaccine-Induced Antitumor Activity Involved in the Enhancement of DC Maturation by Prolonging the Local Retention Time of Antigen and Down-Regulating of IL-6/STAT3.
Journal: International journal of molecular sciences
Published: July 31, 2022
The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice.
Journal: International journal of molecular sciences
Published: July 13, 2020
An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Journal: Molecular medicine reports
Published: July 11, 2018
The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
Journal: Cellular immunology
Published: October 16, 2017
Escherichia coli maltose-binding protein (MBP) activates mouse Th1 through TLR2-mediated MyD88-dependent pathway and TLR4-mediated TRIF-dependent pathway.
Journal: International immunopharmacology
Published: January 20, 2017
The Combination of MBP and BCG-Induced Dendritic Cell Maturation through TLR2/TLR4 Promotes Th1 Activation In Vitro and Vivo.
Journal: Mediators of inflammation
Published: September 06, 2016
Last Updated: 09/26/2026